Based on the data, the use of respiratory system medicine in Canada per thousand persons per day is forecasted to increase as follows:
- 2024: 57.1 units
- 2025: 58.6 units
- 2026: 60.1 units
- 2027: 61.6 units
- 2028: 63.1 units
Year-on-year variations:
- 2025: 2.63%
- 2026: 2.56%
- 2027: 2.50%
- 2028: 2.44%
The Compound Annual Growth Rate (CAGR) over the five-year period (2024-2028) is approximately 2.53%.
Future Trends to Watch: As respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD) become more prevalent, we can anticipate continued growth in the usage of respiratory system medicines. Factors such as aging population, increasing pollution levels, and advancements in drug development will likely drive this upward trend even further.
